Photo of Dr. Hagop Kantarjian from obroncology.com
Apr 26, 2024, 08:09
Hagop Kantarjian: The results of the first clinical trial to explore activin receptor ligand traps of drugs in MF
Hagop Kantarjian, Leukaemia professor and Chair at MD Anderson Cancer Center, shared on X:
”Activin receptor ligand traps continue to show promise in the treatment of anemia of myelofibrosis.
Check out the results of the first clinical trial to explore this class of drugs in MF here Haematologica.”
Source: Hagop Kantarjian/X
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 1, 2025, 12:16
Apr 1, 2025, 12:13
Apr 1, 2025, 12:07
Apr 1, 2025, 11:53
Apr 1, 2025, 11:51
Apr 1, 2025, 11:42